Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Lillian Werner"'
Autor:
James Larkin, Jedd Wolchok, David F McDermott, Michael A Postow, Ahmad A Tarhini, Michael B Atkins, F Stephen Hodi, Corey Ritchings, Brian Stwalley, Andriy Moshyk, Meredith M Regan, Charlene M Mantia, Lillian Werner, Sandra Re, Wim van Dijck
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/d544047750af455e9720b9d2c98d7dc4
Autor:
Mary Nauffal, Lillian Werner, Jian Ni, Richard M. Stone, Daniel J. DeAngelo, Anne M. McDonnell
Publikováno v:
Leukemia Research Reports, Vol 12, Iss , Pp - (2019)
All-trans-retinoic acid (ATRA) is the standard of care for the management of acute promyelocytic leukemia (APL), but can be associated with differentiation syndrome (DS). Over a seven-year period, we sought to determine the impact of ATRA initiation
Externí odkaz:
https://doaj.org/article/8ce22255810742abaaebdf66828f4e54
Autor:
Jan A. Burger, Dan A. Landau, Amaro Taylor-Weiner, Ivana Bozic, Huidan Zhang, Kristopher Sarosiek, Lili Wang, Chip Stewart, Jean Fan, Julia Hoellenriegel, Mariela Sivina, Adrian M. Dubuc, Cameron Fraser, Yulong Han, Shuqiang Li, Kenneth J. Livak, Lihua Zou, Youzhong Wan, Sergej Konoplev, Carrie Sougnez, Jennifer R. Brown, Lynne V. Abruzzo, Scott L. Carter, Michael J. Keating, Matthew S. Davids, William G. Wierda, Kristian Cibulskis, Thorsten Zenz, Lillian Werner, Paola Dal Cin, Peter Kharchencko, Donna Neuberg, Hagop Kantarjian, Eric Lander, Stacey Gabriel, Susan O’Brien, Anthony Letai, David A. Weitz, Martin A. Nowak, Gad Getz, Catherine J. Wu
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-13 (2016)
The BTK inhibitor ibrutinib is used to treat chronic lymphocytic leukaemia, however some patients develop resistance to the drug. Here, the authors use genomic analyses to examine the clonal evolution of 5 patients that develop resistance to ibrutini
Externí odkaz:
https://doaj.org/article/31a1991cd4d64583af26755ec24a7d52
Autor:
Jean-Christophe Pignon, Chiara Grisanzio, Ingrid Carvo, Lillian Werner, Meredith Regan, E Lynette Wilson, Sabina Signoretti
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0128489 (2015)
There is evidence that stem cells and their progeny play a role in the development of the prostate. Although stem cells are also considered to give rise to differentiated progeny in the adult prostate epithelium ex vivo, the cohort of adult prostate
Externí odkaz:
https://doaj.org/article/c3a454f793b94968b7d9667c2b6c44fc
Autor:
Joaquim Bellmunt, Lillian Werner, Jeffrey J Leow, Stephanie A Mullane, André P Fay, Markus Riester, Paul Van Hummelen, Mary-Ellen Taplin, Toni K Choueiri, Eliezer Van Allen, Jonathan Rosenberg
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0124711 (2015)
An integrative analysis was conducted to identify genomic alterations at a pathway level that could predict overall survival (OS) in patients with advanced urothelial carcinoma (UC) treated with platinum-based chemotherapy.DNA and RNA were extracted
Externí odkaz:
https://doaj.org/article/1fd80159b5854ca09a8f19092b7bfff3
Autor:
Joaquim Bellmunt, Shamini Selvarajah, Scott Rodig, Marta Salido, Silvia de Muga, Irmgard Costa, Beatriz Bellosillo, Lillian Werner, Stephanie Mullane, André P Fay, Robert O'Brien, Jordi Barretina, André E Minoche, Sabina Signoretti, Clara Montagut, Heinz Himmelbauer, David M Berman, Philip Kantoff, Toni K Choueiri, Jonathan E Rosenberg
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103325 (2014)
BACKGROUND: Anaplastic lymphoma kinase (ALK) genomic alterations have emerged as a potent predictor of benefit from treatment with ALK inhibitors in several cancers. Currently, there is no information about ALK gene alterations in urothelial carcinom
Externí odkaz:
https://doaj.org/article/bbf5118d3ed9435c9fbb95822615c00c
Autor:
Jennifer R. Brown, Bradley Messmer, Lillian Werner, Matthew S. Davids, Evgeny Mikler, Jeffrey G. Supko, David C. Fisher, Ann S. LaCasce, Philippe Armand, Eric Jacobsen, Virginia Dalton, Bethany Tesar, Stacey M. Fernandes, Sean McDonough, Jerome Ritz, Laura Rassenti, Thomas J. Kipps, Donna Neuberg, Arnold S. Freedman
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia. Twenty-eight patients with relapsed refractory chronic lymphocytic leukemia were treated
Externí odkaz:
https://doaj.org/article/45fb428bc92c4617a92035c93cfe1ae5
Autor:
Rinath M Jeselsohn, Lillian Werner, Meredith M Regan, Aquila Fatima, Lauren Gilmore, Laura C Collins, Andrew H Beck, Shannon T Bailey, Housheng Hansen He, Gilles Buchwalter, Myles Brown, J Dirk Iglehart, Andrea Richardson, Steven E Come
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64225 (2013)
Advancements in molecular biology have unveiled multiple breast cancer promoting pathways and potential therapeutic targets. Large randomized clinical trials remain the ultimate means of validating therapeutic efficacy, but they require large cohorts
Externí odkaz:
https://doaj.org/article/0167b02320db44619be2f68bca433504
Autor:
Shuqiang Li, Howell F Moffett, Jun Lu, Lillian Werner, Hao Zhang, Jerome Ritz, Donna Neuberg, Kai W Wucherpfennig, Jennifer R Brown, Carl D Novina
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e16956 (2011)
Chronic lymphocytic leukemia (CLL) is thought to be a disease of resting lymphocytes. However, recent data suggest that CLL cells may more closely resemble activated B cells. Using microRNA (miRNA) expression profiling of highly-enriched CLL cells fr
Externí odkaz:
https://doaj.org/article/2ef6590ef52f4fd3b983ba2328087aef
Autor:
Matthew L. Freedman, Philip W. Kantoff, William K. Oh, Mari Nakabayashi, Gillian Petrozziello, Carolyn Evan, Tong Sun, Gwo-Shu Mary Lee, Meredith M. Regan, Wanling Xie, Lillian Werner, Mark M. Pomerantz
Supplementary Table S1 from Association of Prostate Cancer Risk Loci with Disease Aggressiveness and Prostate Cancer–Specific Mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e0f7d94e1173f72b5280737583fe1c
https://doi.org/10.1158/1940-6207.22524123.v1
https://doi.org/10.1158/1940-6207.22524123.v1